Two new Directors to join Schroders board
March 7, 2019

Global investment manager Schroders plc has today announced the appointment of two new Directors, Deborah Waterhouse and Leonie Schroder, effective March 11.

Waterhouse, Chief Executive of ViiV Healthcare, will join the Board as an Independent Non-executive Director and Schroder will join as a Non-independent Non-executive Director. Both will join the Nominations Committee.

Robin Buchanan will retire at the conclusion of the Annual General Meeting on May 2, having served nine years on the Board.

Michael Dobson, Chairman of Schroders, said: "For over 40 years the Board has included two Directors with a connection to the principal shareholder group. We believe that having two members of the family serving on the Board benefits the company in aligning interests and reinforcing long term thinking. Following these appointments, we will continue to have a majority of Independent Non-executive Directors on the Board."

Bruno Schroder, who died on 20 February 2019, was anticipating retiring from the Board at the Annual General Meeting on 2 May 2019. Consequently, the Nominations Committee gave consideration in 2018 to his succession, consulting with the trustees of the family trusts and other members of the principal shareholder group.

Following those consultations, the Committee received from the trustees of the family trusts a proposal that Leonie Schroder was their preferred candidate to succeed Bruno Schroder. After careful consideration, the Nominations Committee decided to recommend her appointment.

As part of the nominations process, the Company also engaged with a number of major institutional shareholders. All indicated support for the proposal to appoint Leonie Schroder, given the overall mix of skills on the Board and the majority of Independent Non-executive Directors.

Waterhouse, 51, has been the CEO of ViiV Healthcare since 2017. ViiV Healthcare is a leading global company, majority owned by GlaxoSmithKline and focused on advancing science into HIV treatment, prevention and care. In 2018 ViiV Healthcare generated sales of 4.7 billion. Waterhouse has more than two decades of experience in the pharmaceuticals sector.

Schroder, 44, is a descendant of John Henry Schroder, co-founder of Schroders in 1804. She has held a number of roles in the charity sector and is currently a Director of the Schroder Charity Trust and a number of private limited companies.





This site, like many others, uses small files called cookies to customize your experience. Cookies appear to be blocked on this browser. Please consider allowing cookies so that you can enjoy more content across fundservices.net.

How do I enable cookies in my browser?

Internet Explorer
1. Click the Tools button (or press ALT and T on the keyboard), and then click Internet Options.
2. Click the Privacy tab
3. Move the slider away from 'Block all cookies' to a setting you're comfortable with.

Firefox
1. At the top of the Firefox window, click on the Tools menu and select Options...
2. Select the Privacy panel.
3. Set Firefox will: to Use custom settings for history.
4. Make sure Accept cookies from sites is selected.

Safari Browser
1. Click Safari icon in Menu Bar
2. Click Preferences (gear icon)
3. Click Security icon
4. Accept cookies: select Radio button "only from sites I visit"

Chrome
1. Click the menu icon to the right of the address bar (looks like 3 lines)
2. Click Settings
3. Click the "Show advanced settings" tab at the bottom
4. Click the "Content settings..." button in the Privacy section
5. At the top under Cookies make sure it is set to "Allow local data to be set (recommended)"

Opera
1. Click the red O button in the upper left hand corner
2. Select Settings -> Preferences
3. Select the Advanced Tab
4. Select Cookies in the list on the left side
5. Set it to "Accept cookies" or "Accept cookies only from the sites I visit"
6. Click OK

Global investment manager Schroders plc has today announced the appointment of two new Directors, Deborah Waterhouse and Leonie Schroder, effective March 11.

Waterhouse, Chief Executive of ViiV Healthcare, will join the Board as an Independent Non-executive Director and Schroder will join as a Non-independent Non-executive Director. Both will join the Nominations Committee.

Robin Buchanan will retire at the conclusion of the Annual General Meeting on May 2, having served nine years on the Board.

Michael Dobson, Chairman of Schroders, said: "For over 40 years the Board has included two Directors with a connection to the principal shareholder group. We believe that having two members of the family serving on the Board benefits the company in aligning interests and reinforcing long term thinking. Following these appointments, we will continue to have a majority of Independent Non-executive Directors on the Board."

Bruno Schroder, who died on 20 February 2019, was anticipating retiring from the Board at the Annual General Meeting on 2 May 2019. Consequently, the Nominations Committee gave consideration in 2018 to his succession, consulting with the trustees of the family trusts and other members of the principal shareholder group.

Following those consultations, the Committee received from the trustees of the family trusts a proposal that Leonie Schroder was their preferred candidate to succeed Bruno Schroder. After careful consideration, the Nominations Committee decided to recommend her appointment.

As part of the nominations process, the Company also engaged with a number of major institutional shareholders. All indicated support for the proposal to appoint Leonie Schroder, given the overall mix of skills on the Board and the majority of Independent Non-executive Directors.

Waterhouse, 51, has been the CEO of ViiV Healthcare since 2017. ViiV Healthcare is a leading global company, majority owned by GlaxoSmithKline and focused on advancing science into HIV treatment, prevention and care. In 2018 ViiV Healthcare generated sales of 4.7 billion. Waterhouse has more than two decades of experience in the pharmaceuticals sector.

Schroder, 44, is a descendant of John Henry Schroder, co-founder of Schroders in 1804. She has held a number of roles in the charity sector and is currently a Director of the Schroder Charity Trust and a number of private limited companies.



Free subscription - selected news and optional newsletter
Premium subscription
  • All latest news
  • Latest special reports
  • Your choice of newsletter timing and topics
Full-access magazine subscription
  • 7-year archive of news
  • All past special reports
  • Newsletter with your choice of timing and topics
  • Access to more content across the site